CD1D and neoplasm: Recent studies have begun to elucidate a novel immunoregulatory axis of CD1d-restricted NKT cells, with type I invariant NKT (iNKT) having antitumor functions, and type II variant NKT cells demonstrating mainly immunosuppressive tumor-promoting abilities [14].